
Body scans can measure lean mass, fat inside muscle, and fat around the organs. (Photo by Accuray from Unsplash)
Fat Inside Muscle Complicates the Lean Mass and Health Link
In A Nutshell
- More total lean mass tracked with higher metabolic syndrome rates.
- Lean mass as a share of weight showed the opposite pattern.
- Muscle fat and belly fat may help explain the split.
- A single snapshot cannot show cause and effect.
More muscle is supposed to mean better health. A study of 59,269 adults in the United Kingdom found a puzzling pattern: people with the highest total lean mass, a measure that counts everything in the body except fat, were more likely to have metabolic syndrome and elevated blood sugar.
Metabolic syndrome is a cluster of warning signs, including a large waistline, high blood pressure, and unhealthy cholesterol and blood sugar, that raises the odds of diabetes and heart disease. Muscle soaks up more blood sugar in response to insulin than any other tissue, so more of it should help, not hurt.
Lean mass is not the same as muscle, though. It also counts organs, bone, and body water. Researchers at Pennington Biomedical Research Center point to two possible explanations in The Journal of Clinical Endocrinology & Metabolism: fat tucked inside muscle and fat stored deep around the belly’s organs. The data show links, not cause and effect.
More Total Lean Mass Tracked With Higher Metabolic Syndrome Rates
Data came from the UK Biobank, a large British health project that recruited adults between 2006 and 2010. This analysis included 59,269 participants, 28,587 men and 30,682 women, who averaged about 55 years old, and more than 96 percent identified as white. Each had an x-ray scan that measured lean mass and fat, plus MRI scans that measured fat inside the thigh muscles and fat packed around the abdominal organs.
About 20 percent, or 12,073 people, met the criteria for metabolic syndrome, and roughly 12 percent had elevated long-term blood sugar, as shown by a blood test called HbA1c. Researchers split men and women separately into three equal groups, lowest to highest, using three lean mass measures: the total amount, the amount for a given height, and the share of body weight. They then checked whether muscle fat, belly fat, or sex hormones changed the picture, using smaller subsets of participants for those tests.
Metabolic syndrome rates climbed with total lean mass, from 13.3 percent in the lowest third to 28.1 percent in the highest. Lean mass for a given height followed the same climb, as did elevated blood sugar.
Measured as a share of body weight, the pattern flipped, with metabolic syndrome affecting 35.9 percent of the lowest third and 7.5 percent of the highest. Bigger bodies tend to carry more lean tissue and more fat together, while a larger lean share leaves less room for fat, a likely reason for the reversal.
Fat Inside Muscle Modestly Strengthened Lean Mass Links to Metabolic Problems
Fat marbled inside muscle, like the white streaks in a steak, was measured in the thighs. Among people with more of it, extra total lean mass went with a slightly higher chance of metabolic syndrome and elevated blood sugar. More muscle fat also dulled the protection seen in people whose lean mass made up a bigger share of their weight, at least for metabolic syndrome. Authors called this the central finding of their study, though they described the effects as modest.
Lean tissue in the arms and legs, a closer stand-in for muscle, showed a similar result for blood sugar, and the authors wrote that “quantity without quality is insufficient.”
Belly Fat Had the Strongest Influence on Metabolic Syndrome Links
Fat stored deep around the organs, called visceral fat, influenced the lean mass link more than anything else tested. Among people with more of it, the connection between total lean mass and metabolic syndrome was weaker, so the authors said part of that connection could be traced to belly fat.
Accounting for belly fat shook up the muscle fat results for metabolic syndrome. The earlier patterns for total lean mass and for lean share of body weight faded, and a new one appeared for lean mass at a given height, pointing the opposite way: more muscle fat went with a slightly weaker link between lean mass and metabolic syndrome. The authors read the new pattern as a sign that fat in muscle reveals something about risk that belly fat alone does not.
Sex Hormones Had Only Modest Effects on the Lean Mass Link
Higher testosterone went with a slightly weaker link between total lean mass and both metabolic syndrome and elevated blood sugar, though not clearly when men and women were analyzed separately. A protein that carries sex hormones through the blood slightly weakened the protection seen in people whose lean mass made up a bigger share of their weight, and estrogen did the same for blood sugar. Authors said hormones contribute but do not override the influence of muscle fat and belly fat.
A bigger lean mass number is not automatically a healthier one, and the x-ray scan used here, like other common body composition tests, cannot separate muscle from organs, bone, and water or detect fat inside muscle. With only a single snapshot of each person and no exercise tested, the study says nothing about whether gaining muscle helps or harms.
Disclaimer: This article summarizes published research and is not medical advice. Consult a health care professional with questions.
Paper Notes
Limitations
This was a cross-sectional study, meaning it captured a single snapshot in time rather than following people over years, so it cannot show that fat inside muscle or belly fat causes metabolic problems. Metabolic syndrome and elevated HbA1c served as stand-ins for insulin resistance, which is hard to measure directly in large groups. Muscle fat was measured only in the thighs and used to represent the whole body, which may have underestimated its effect. Sex hormones were measured at one point in time, which ignores daily and age-related swings. Sample sizes varied by analysis, from fewer than 7,000 people in the estrogen analyses to about 36,800 in the belly fat analyses, because not everyone had every measurement. Participants were more than 96 percent white by self-report, according to the paper’s Table 1, so results may not apply equally to other groups.
Funding and Disclosures
Support came in part from the National Institute on Aging (grants R00AG065419 and R01AG092725 to Candida J. Rebello), a Nutrition and Obesity Research Center grant (P30DK072476) from the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institute of General Medical Sciences, which funds the Louisiana Clinical and Translational Science Center (U54 GM104940). The authors state that the content is solely their responsibility and does not necessarily represent the official views of the National Institutes of Health. They declare no competing financial interests. The research used the UK Biobank Resource under application number 117233.
Publication Details
Titled “Relationship between fat-free mass and metabolic syndrome is shaped by ectopic fat in a UK Biobank cohort,” the study was written by Sri Lakshmi Devarakonda, Dachuan Zhang, Reilly Roberts, and Candida Rebello of Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana. Correspondence went to Candida J. Rebello, PhD, RD. It appeared in The Journal of Clinical Endocrinology & Metabolism, published by Oxford University Press on behalf of the Endocrine Society, as an open-access advance article on October 8, 2026 (received May 11, 2026; accepted September 29, 2026). The DOI is 10.1210/clinem/dgag407 (https://doi.org/10.1210/clinem/dgag407). Suggested citation: Devarakonda SL, Zhang D, Roberts R, Rebello C. Relationship between fat-free mass and metabolic syndrome is shaped by ectopic fat in a UK Biobank cohort. J Clin Endocrinol Metab. 2026;dgag407.







